Identification and validation of diagnostic markers of atherosclerosis progression via bioinformatics strategies
PLOS One · 2025
DOI: 10.1371/journal.pone.0336139 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Yun Mao und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, People's Republic of China. Hauptthemen laut MEDLINE: Computational Biology, Atherosclerosis. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Henan Provincial Science and Technology Research Project.
Abstract (Originalsprache)
Background
Arteriosclerosis (AS) is a leading cause of cardiovascular disease, imposing significant burdens on families and society. However, the underlying mechanisms remain unclear. This study aims to elucidate these mechanisms and explore potential pharmacological treatments through the integration of bioinformatics.
Methods
The GSE28829 dataset was retrieved from the GEO database. Differential gene expression between early- and late-stage AS plaques in GSE28829 was identified via the limma package. We focused on the intersecting genes associated with endoplasmic reticulum stress and mitochondrial damage. LASSO regression analysis was applied to pinpoint potential core genes associated with AS. An protein interaction network was constructed, with a focus on the hub genes within this network. Assessment of immune cell infiltration levels was achieved via the ssGSEA method and confirmed via CIBERSORT. We used the DrugBank database to predict small molecule drugs that could intervene in AS progression.
Results
In this study, DEGs associated with AS were identified, and hub genes, including FCGR3A, ITGB2, TYROBP, FCGR2B, CTSS, FCER1G, CD86, TLR2, C1QB, and C1QA , were identified. We also found a strong correlation between the hub genes and immune processes, indicating that ER stress and mitochondrial damage were correlated with the activation of immune processes. Additionally, a diagnostic model for AS was established, demonstrating the substantial predictive value of these hub genes.
Conclusions
This study reveals the involvement of genes related to endoplasmic reticulum stress and mitochondrial damage in the pathogenesis of AS. These hub genes offer new directions for further research and the development of pharmacological treatments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, People's Republic of China.
- Centre for Cardiovascular Diseases, Henan Key Laboratory of Hereditary Cardiovascular Diseases, Zhengzhou, People's Republic of China.
- Department of Critical Care Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
ORCID-Profile: Yun Mao
Förderung
- National Natural Science Foundation of China
- Henan Provincial Science and Technology Research Project
Zitieren
APA
Mao, Y., Xiao, Y., & Hu, X. (2025). Identification and validation of diagnostic markers of atherosclerosis progression via bioinformatics strategies. PLOS One. https://doi.org/10.1371/journal.pone.0336139
Vancouver
Mao Y, Xiao Y, Hu X. Identification and validation of diagnostic markers of atherosclerosis progression via bioinformatics strategies. PLOS One. 2025. doi:10.1371/journal.pone.0336139
BibTeX
@article{Mao2025,
author = {Mao, Yun and Xiao, Yang and Hu, Xia},
title = {Identification and validation of diagnostic markers of atherosclerosis progression via bioinformatics strategies},
journal = {PLOS One},
year = {2025},
doi = {10.1371/journal.pone.0336139}
}
EUVIMED